1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea (Compound)

Pubchem:PUBCHEM:156422

Id:677f70b0-97b5-5ea0-abbe-eb4c14469f20

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea.

Results found

Linked to

	Label	Description
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates GATM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Tyrosine-protein kinase receptor Tie-1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates MAP7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates S100A9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	(-)-adrenaline in similarity relationship with 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Mitogen-activated protein kinase 9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Epithelial discoidin domain-containing receptor 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates ME1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates C7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates PLAT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates GATM

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Tyrosine-protein kinase receptor Tie-1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates MAP7

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates S100A9

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

(-)-adrenaline in similarity relationship with 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Mitogen-activated protein kinase 9

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea bioactivity Epithelial discoidin domain-containing receptor 1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea negatively regulates ME1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates C7

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea positively regulates PLAT

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.